Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies.
Gajic-Veljanoski O, Li C, Schaink AK, Guo J, Shehata N, Charames GS, de Vrijer B, Clarke G, Pechlivanoglou P, Okun N, Kandel R, Dooley J, Higgins C, Ng V, Sikich N.
Gajic-Veljanoski O, et al. Among authors: ng v.
Transfusion. 2022 May;62(5):1089-1102. doi: 10.1111/trf.16826. Epub 2022 Feb 16.
Transfusion. 2022.
PMID: 35170037